Skip to content

Cardiovascular Biomarkers and Lung Edema in Severe Burns Patients

The Role of CARdiovascular biOmarkers (NT-pro-BNP and CD146) in Predicting Lung Edema in Severely Burned Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03271268
Acronym
CAROLE
Enrollment
36
Registered
2017-09-05
Start date
2017-08-06
Completion date
2019-04-06
Last updated
2017-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Keywords

Vascular filling, Fluid overload, Biomarkers, Lung edema

Brief summary

Burn injury leads to hypovolemic then distributive shock. Fluid resuscitation remains the cornerstone of initial treatment of burn shock. However, fluid rescucitation can lead to fluid overload, which manifests most notably as lung edema. The peptide NT-pro-BNP, a biomarker of cardiac congestion secreted by the myocardium, as well as plasma CD146, an endothelial factor involved in angiogenesis and a marker of vascular congestion, may help identifying patients with risk of pulmonary edema and hypoxia . Our hypothesis is that these biomarkers may predict the occurence of pulmonary edema in severe burns patients.

Interventions

None listed

Sponsors

Saint-Louis Hospital, Paris, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Intubated mechanically-ventilated patients within the first 24 hours of admission * And/or patients with total body surface area (TBSA) burn-injured \>20 % * And/or patients with at least 10% full-thickness burns * And/or receiving vasopressors within the first 24 hours of admission * And monitored by a PiCCO system (PiCCO-2 Pulsion Medical Systems AG, Munich, Germany)

Exclusion criteria

* Admission delay to ICU \> 24 hours post burn * Age less than 18 years * Pregnancy * Chronic renal impairment with a baseline eGFR \< 15 ml/min * Patients with chemical or electrical burns * Coexisting non-burn trauma * Patients moribund on admission or dead within 72 h from admission * Patients with do-not-resuscitate orders

Design outcomes

Primary

MeasureTime frameDescription
Lung edemaDuring the first 7 days of admissionExtravascular lung water (EVLW) \> 10 mL/Kg as measured by transpulmonary thermodilution (TPTD)

Secondary

MeasureTime frameDescription
HypercapniaDuring the first 7 days of admission for mechanically-ventilated patientsPaCO2\> 45 mmHg
Corrected minute ventilation > 10L/minDuring the first 7 days of admission for mechanically-ventilated patientsMinute ventilation × partial \[Paco2\]/40) \> 10L/min
Multiple organ dysfunction syndrome (MODS)During the first 7 days of admissionSequential Organ Failure Assessment score (SOFA) ≥ 8
HypoxemiaDuring the first 7 days of admission for mechanically-ventilated patientsPaO2/FiO2 ratio of \<200
90-day mortality90 days
Length of stay in the ICUuntil 90 days of hospitalization
28-day mortality28 days

Countries

France

Contacts

Primary ContactSabri Soussi, MD
sabri.soussi@gmail.com0613064542
Backup ContactMatthieu Legrand, MD, PhD
matthieu.m.legrand@gmail.com0685104235

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026